The versatile actor of Bollywood Irrfan Khan was recently seen in Karwaan, where we all were mesmerized by his performance. But unfortunately, he was not here for the promotions as from past 5 months he is in London, where he is undergoing a treatment for a neuroendocrine tumour. Due to his medical condition, the actor has left many projects and to add one more, the actor, who was supposed to be a show with AIB team will not be able to do it now as his current physical health demands rest for speedy recovery. The actor shared the message with a post on his official FB account and thanked the creative team for understanding his condition. He also wrote that he is excited for the project and can't hide his excitement for the final outcome.
Vijay Subramaniam, Director and Head, Content, Amazon Prime Video, India also confirmed the news and said in a statement, “Irrfan Khan, actor extraordinaire and star of Amazon Prime Original Series, ‘Gormint’ (formerly known as ‘Ministry’) today announced the joint decision by the creators and him to no longer be cast in the show owing to his health situation. Amazon Prime Video, along with the show’s creators and cast, are deeply saddened by this news. Irrfan has been – and will continue to remain a part of the Amazon family. We wish him a speedy and successful recovery and look forward to watching the show with him sitting right next to us.”
The actor recently opened about his chemotherapy cycles and said, “I have had the fourth cycle of chemo. And I have to have six cycles and then we need to have a scan. After the third cycle, the scan was positive. But we need to see after the sixth scan. And then we’ll see where it takes me.” We wish for Irrfan's speedy and successful recovery and hope that he comes back on the silver screen very soon to entertain us.
Stay tuned to BollywoodLife for the latest scoops and updates from Bollywood, Hollywood, South, TV and Web-Series.
Click to join us on Facebook, Twitter, Youtube and Instagram. Also follow us on Facebook Messenger for latest updates.